Back
Supernus Pharmaceuticals, Inc. Stock Predictions
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
SUPN
Supernus Pharmaceuticals, Inc.
Last Price:
$51.64
Seasonality Move:
4.69%
7 Day Trial
ALL ACCESS PASS
$
7
The Next AI Breakouts Won't Talk Like ChatGPT
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comSupernus Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 21.3% based on the past 13 years of stock performance.
-
Supernus Pharmaceuticals, Inc. has risen higher in 8 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
-
Is Supernus Pharmaceuticals, Inc. Stock Undervalued?The current Supernus Pharmaceuticals, Inc. [SUPN] share price is $51.65. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 21.3% based on the past 13 years of stock performance.
Supernus Pharmaceuticals, Inc. Stock Rating
Sell
41
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Is Supernus Pharmaceuticals, Inc. overpriced?
-
Supernus Pharmaceuticals, Inc. has risen higher in 8 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
Supernus Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
57.65
52-Week Low:
29.16
Prediction Charts
Market Cap:
3B
Price in USD:
51.65
Volume:
894K
Beta:
1.08
Technical Analysis
SMA50:
48.85
SMA100:
48.69
SMA200:
42.24
52-Wk Change:
32.95%
Stock Predictions
-
Is Supernus Pharmaceuticals, Inc. stock public?Yes, Supernus Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Supernus Pharmaceuticals, Inc. stock quote today?The Supernus Pharmaceuticals, Inc. stock price is 51.65 USD today.
-
How to buy Supernus Pharmaceuticals, Inc. stock online?You can buy Supernus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 49.72 | 49.82 | 50.55 | 48.88 |
| Jan-21 | 49.65 | 49.52 | 50.25 | 48.84 |
| Jan-22 | 49.68 | 49.10 | 50.46 | 48.98 |
| Jan-23 | 48.81 | 48.25 | 49.04 | 47.94 |
| Jan-26 | 48.07 | 49.16 | 49.67 | 48.07 |
| Jan-27 | 49.11 | 49.44 | 49.53 | 48.73 |
| Jan-28 | 49.41 | 48.94 | 50.09 | 48.41 |
| Jan-29 | 48.74 | 49.06 | 49.36 | 48.04 |
| Jan-30 | 48.73 | 48.16 | 49.07 | 48.02 |
| Feb-2 | 48.15 | 48.78 | 49.49 | 48.11 |
| Feb-3 | 48.86 | 48.40 | 49.71 | 47.29 |
| Feb-4 | 48.42 | 49.08 | 49.47 | 48.20 |
| Feb-5 | 48.98 | 49.37 | 50.10 | 48.93 |
| Feb-6 | 50.01 | 51.65 | 51.99 | 50.01 |
Supernus Pharmaceuticals, Inc. Earnings
Supernus Pharmaceuticals, Inc. Earnings Report: Per Share Supernus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals, Inc. Forecast Revenue Growth
Supernus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $1.53 per share.
* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.